{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
romidepsin
to a specific field?
There is one exact (name or code) match for romidepsin
Status:
US Approved Rx
(2021)
Source:
ANDA206254
(2021)
Source URL:
First approved in 2009
Source:
NDA022393
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
FR-135313 (also known as Romidepsin reduced) was studied as a selective inhibitor of the human histone deacetylase 1 (HDAC1).
Showing 1 - 6 of 6 results
Status:
US Approved Rx
(2021)
Source:
ANDA206254
(2021)
Source URL:
First approved in 2009
Source:
NDA022393
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
FR-135313 (also known as Romidepsin reduced) was studied as a selective inhibitor of the human histone deacetylase 1 (HDAC1).
Status:
US Approved Rx
(2021)
Source:
ANDA206254
(2021)
Source URL:
First approved in 2009
Source:
NDA022393
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
FR-135313 (also known as Romidepsin reduced) was studied as a selective inhibitor of the human histone deacetylase 1 (HDAC1).
Status:
Possibly Marketed Outside US
Source:
Octaplasma by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:
First approved in 2013
Source:
BLA125416
Source URL:
Class:
MIXTURE
Status:
Other
Class:
STRUCTURALLY DIVERSE
